SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-21-170922
Filing Date
2021-05-24
Accepted
2021-05-24 16:30:38
Documents
3
Group Members
ATAI LIFE SCIENCES AG

Document Format Files

Seq Description Document Type Size
1 SC 13D d185824dsc13d.htm SC 13D 75558
2 EX-99.1 d185824dex991.htm EX-99.1 4658
3 EX-99.5 d185824dex995.htm EX-99.5 162899
  Complete submission text file 0001193125-21-170922.txt   244738
Mailing Address 6420 ABRAMS SAINT LAURENT A8 H4S 1Y2
Business Address 6420 ABRAMS SAINT LAURENT A8 H4S 1Y2 514-331-7440
IntelGenx Technologies Corp. (Subject) CIK: 0001098880 (see all company filings)

IRS No.: 870638336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-82768 | Film No.: 21955383
SIC: 2834 Pharmaceutical Preparations

Mailing Address 180 VARICK STREET NEW YORK NY 10014
Business Address 180 VARICK STREET NEW YORK NY 10014 (617) 699-5876
ATAI Life Sciences B.V. (Filed by) CIK: 0001840904 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations